CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 93 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $612,000 | -0.8% | 48,453 | -22.9% | 0.00% | 0.0% |
| Q3 2020 | $617,000 | +115.0% | 62,853 | +117.9% | 0.00% | 0.0% |
| Q2 2020 | $287,000 | +46.4% | 28,850 | +30.4% | 0.00% | 0.0% |
| Q1 2020 | $196,000 | +53.1% | 22,126 | +59.2% | 0.00% | – |
| Q4 2019 | $128,000 | -97.1% | 13,900 | -95.3% | 0.00% | -100.0% |
| Q3 2018 | $4,420,000 | -12.9% | 297,864 | -1.3% | 0.01% | -16.7% |
| Q2 2018 | $5,077,000 | -24.1% | 301,650 | +3.3% | 0.01% | -20.0% |
| Q1 2018 | $6,686,000 | +137.8% | 291,950 | +168.6% | 0.02% | +114.3% |
| Q4 2017 | $2,812,000 | – | 108,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |